A director exercises warrants at $0.0004 per depositary share in Akari Therapeutics (AKTX).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Akari Therapeutics director Sandip I. Patel exercised pre-funded warrants for 10,052 ADSs at $0.0004 per share and received RSU awards for 16,413 ADSs and options for 60,000 ADSs. These RSU and option grants are subject to shareholder approval of an equity plan amendment and have specific vesting schedules.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.